SCHEMBL13432205

SCHEMBL13432205

CN1CCC(C2CCN(S(C)(=O)=O)CC2)CC1

nearest known ligand 0.47

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
TP53 P04637 1/20 0.47
TSHR P16473 3/20 0.42
SMN1; SMN2 Q16637 2/20 0.42
MAPT P10636 2/20 0.41
ALDH1A1 P00352 2/20 0.40
POLB P06746 1/20 0.40
CYP2C19 P33261 1/20 0.40
L3MBTL1 Q9Y468 2/20 0.39
NPSR1 Q6W5P4 2/20 0.39
GNAI3 P08754 1/20 0.38
GNAO1 P09471 1/20 0.38
GNAI1 P63096 1/20 0.38
KDM4E B2RXH2 1/20 0.38
HTT P42858 2/20 0.38
MEN1 O00255 3/20 0.37
KMT2A Q03164 3/20 0.37
GAA P10253 1/20 0.37
LMNA P02545 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL48487 0.79 POLB (0.45) TP53TSHRSMN1; SMN2MAPTALDH1A1
SCHEMBL22171142 0.79 ALDH1A1 (0.53) TP53TSHRSMN1; SMN2MAPTALDH1A1
SCHEMBL2735017 0.79 GNAI3 (0.50) MAPTALDH1A1POLBGNAI3GNAO1
SCHEMBL15450981 0.79 ALDH1A1 (0.53) TP53TSHRSMN1; SMN2MAPTALDH1A1
SCHEMBL13713287 0.79 ALDH1A1 (0.57) TP53SMN1; SMN2MAPTALDH1A1L3MBTL1
SCHEMBL429660 0.78 TP53 (0.48) TP53TSHRSMN1; SMN2MAPTALDH1A1
SCHEMBL2164158 0.77 TP53 (0.44) TP53TSHRSMN1; SMN2MAPTALDH1A1
SCHEMBL6985188 0.77 TP53 (0.44) TP53TSHRSMN1; SMN2MAPTALDH1A1
SCHEMBL1773952 0.77 TP53 (0.52) TP53TSHRSMN1; SMN2MAPTALDH1A1
SCHEMBL19343096 0.76 GNAI3 (0.48) MAPTALDH1A1POLBGNAI3GNAO1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7696195-B2 Selected CGRP-antagonists, process for preparing them and their use as pharmaceutical compositions BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2010-04-13 US disclosed
US-7205294-B2 Selected CGRP-antagonists process for preparing them and their use as pharmaceutical compositions BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2007-04-17 US disclosed
US-7205294-B2 Selected CGRP-antagonists process for preparing them and their use as pharmaceutical compositions BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2007-04-17 US disclosed